{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:45:24Z","timestamp":1790847924391,"version":"4.1.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.canlet.2015.12.022","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T09:18:21Z","timestamp":1453972701000},"page":"340-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":211,"title":["Regulation of prostate cancer progression by the tumor microenvironment"],"prefix":"10.1016","volume":"380","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7586-2885","authenticated-orcid":false,"given":"Stephen L.","family":"Shiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina Chia-Yi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leland W.K.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2015.12.022_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clgc.2014.07.003","article-title":"Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results database","volume":"13","author":"Shukla","year":"2015","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.canlet.2015.12.022_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin"},{"key":"10.1016\/j.canlet.2015.12.022_bib0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"De Marzo","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2015.12.022_bib0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00011-015-0812-2","article-title":"Inflammation and prostate cancer: friends or foe?","volume":"64","author":"Taverna","year":"2015","journal-title":"Inflamm. Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2015.12.022_bib0035","first-page":"4792","article-title":"Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer","volume":"9","author":"Ayala","year":"2003","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0040","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0022-5347(05)65620-0","article-title":"Reactive stroma in prostate cancer progression","volume":"166","author":"Tuxhorn","year":"2001","journal-title":"J. Urol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0045","doi-asserted-by":"crossref","first-page":"10123","DOI":"10.1158\/0008-5472.CAN-07-3127","article-title":"Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts","volume":"67","author":"Zeisberg","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0050","doi-asserted-by":"crossref","first-page":"e12920","DOI":"10.1371\/journal.pone.0012920","article-title":"Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth","volume":"5","author":"Placencio","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2015.12.022_bib0055","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1158\/1078-0432.CCR-08-1899","article-title":"Global gene expression analysis of reactive stroma in prostate cancer","volume":"15","author":"Dakhova","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0060","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1158\/0008-5472.CAN-08-2492","article-title":"Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis","volume":"68","author":"Sung","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0065","first-page":"8135","article-title":"Malignant transformation in a nontumorigenic human prostatic epithelial cell line","volume":"61","author":"Hayward","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1290\/1071-2690(2001)037<0127:PPAGCO>2.0.CO;2","article-title":"Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel","volume":"37","author":"Rhee","year":"2001","journal-title":"In Vitro Cell. Dev. Biol. Anim"},{"key":"10.1016\/j.canlet.2015.12.022_bib0075","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/bjc.1997.524","article-title":"Can cancer cells transform normal host cells into malignant cells?","volume":"76","author":"Pathak","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2015.12.022_bib0080","first-page":"5002","article-title":"Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium","volume":"59","author":"Olumi","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2013.12.005","article-title":"Regulation of the anti-tumour immune response by cancer-associated fibroblasts","volume":"25","author":"Harper","year":"2014","journal-title":"Semin. Cancer Biol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0090","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1158\/0008-5472.CAN-13-2259","article-title":"Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15","volume":"74","author":"Bruzzese","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0095","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1090922","article-title":"TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia","volume":"303","author":"Bhowmick","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.canlet.2015.12.022_bib0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"EL Andaloussi","year":"2013","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1016\/j.canlet.2015.12.022_bib0105","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1038\/onc.2014.212","article-title":"Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis","volume":"34","author":"Josson","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.12.022_bib0110","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1158\/1078-0432.CCR-14-0305","article-title":"miR-409-3p\/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer","volume":"20","author":"Josson","year":"2014","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0115","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1158\/1078-0432.CCR-14-1784","article-title":"miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer","volume":"20","author":"Gururajan","year":"2014","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0120","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1530\/ERC-12-0085","article-title":"The reactive stroma microenvironment and prostate cancer progression","volume":"19","author":"Barron","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.canlet.2015.12.022_bib0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrclinonc.2014.72","article-title":"Evolution of androgen receptor targeted therapy for advanced prostate cancer","volume":"11","author":"Wong","year":"2014","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2015.12.022_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2015.12.022_bib0140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-032414-112043","article-title":"Innate immune recognition of cancer","volume":"33","author":"Woo","year":"2015","journal-title":"Annu. Rev. Immunol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Sci"},{"key":"10.1016\/j.canlet.2015.12.022_bib0150","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2015.12.022_bib0155","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.immuni.2014.09.014","article-title":"Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression","volume":"41","author":"Chittezhath","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2015.12.022_bib0160","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/eji.201444999","article-title":"Development of thymic Foxp3(+) regulatory T cells: TGF-beta matters","volume":"45","author":"Chen","year":"2015","journal-title":"Eur. J. Immunol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0165","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.yexmp.2008.11.010","article-title":"Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma","volume":"86","author":"Hussein","year":"2009","journal-title":"Exp. Mol. Pathol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0170","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1055-9965.EPI-13-1126","article-title":"Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial","volume":"23","author":"Gurel","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"10.1016\/j.canlet.2015.12.022_bib0175","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development","volume":"6","author":"de Visser","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2015.12.022_bib0180","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nrclinonc.2015.105","article-title":"Inflammation and cancer: advances and new agents","volume":"12","author":"Crusz","year":"2015","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0185","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pharmthera.2015.06.011","article-title":"The DNA damage response and immune signaling alliance: is it good or bad? Nature decides when and where","volume":"154","author":"Pateras","year":"2015","journal-title":"Pharmacol. Ther"},{"key":"10.1016\/j.canlet.2015.12.022_bib0190","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","article-title":"The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation","volume":"60","author":"De Nunzio","year":"2011","journal-title":"Eur. Urol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0195","first-page":"5857","article-title":"Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression","volume":"60","author":"Shimura","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0200","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/j.1464-410X.2010.09804.x","article-title":"Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer","volume":"107","author":"Nonomura","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.canlet.2015.12.022_bib0205","doi-asserted-by":"crossref","first-page":"486798","DOI":"10.1155\/2014\/486798","article-title":"The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy","volume":"2014","author":"Lanciotti","year":"2014","journal-title":"Biomed Res. Int"},{"key":"10.1016\/j.canlet.2015.12.022_bib0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000342396","article-title":"Immunohistochemical analysis of inflammatory cells in benign and precancerous lesions and carcinoma of the prostate","volume":"80","author":"Fujii","year":"2013","journal-title":"Pathobiology"},{"key":"10.1016\/j.canlet.2015.12.022_bib0215","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/onc.2013.191","article-title":"Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression","volume":"33","author":"Comito","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.12.022_bib0220","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1158\/0008-5472.CAN-14-0992","article-title":"CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy","volume":"75","author":"Escamilla","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0225","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1158\/0008-5472.CAN-12-3981","article-title":"CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer","volume":"73","author":"Xu","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0230","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/bjc.2015.74","article-title":"Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer","volume":"112","author":"Mahon","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2015.12.022_bib0235","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1172\/JCI69369","article-title":"Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis","volume":"123","author":"Liu","year":"2013","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.canlet.2015.12.022_bib0240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jim.2009.06.004","article-title":"Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients","volume":"348","author":"Gannon","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.canlet.2015.12.022_bib0245","doi-asserted-by":"crossref","first-page":"14360","DOI":"10.18632\/oncotarget.3965","article-title":"Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer","volume":"6","author":"Pasero","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2015.12.022_bib0250","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2353\/ajpath.2010.100070","article-title":"Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy","volume":"177","author":"Johansson","year":"2010","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0255","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/pros.20948","article-title":"Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis","volume":"69","author":"Fleischmann","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2015.12.022_bib0260","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1158\/0008-5472.CAN-11-1637","article-title":"Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers","volume":"71","author":"Pittoni","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0265","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/cncr.28890","article-title":"Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio","volume":"120","author":"Templeton","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2015.12.022_bib0270","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1111\/bju.12531","article-title":"Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel","volume":"114","author":"Nuhn","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.canlet.2015.12.022_bib0275","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1158\/0008-5472.CAN-12-3228","article-title":"Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling","volume":"73","author":"Fang","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0280","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0090-4295(00)00519-7","article-title":"Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer","volume":"55","author":"Okada","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2015.12.022_bib0285","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/0008-5472.CAN-11-3110","article-title":"The dark side of mast cell-targeted therapy in prostate cancer","volume":"72","author":"Pittoni","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0290","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1155\/2013\/478303","article-title":"Mast cells as a potential prognostic marker in prostate cancer","volume":"35","author":"Taverna","year":"2013","journal-title":"Dis. Markers"},{"key":"10.1016\/j.canlet.2015.12.022_bib0295","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00262-010-0897-y","article-title":"Identification and characterization of a tumor infiltrating CD56(+)\/CD16 (\u2212) NK cell subset with specificity for pancreatic and prostate cancer cell lines","volume":"59","author":"Frankel","year":"2010","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1016\/j.canlet.2015.12.022_bib0300","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/2326-6066.CIR-14-0227","article-title":"Preexisting levels of CD4 T cells expressing PD-1 are related to overall survival in prostate cancer patients treated with ipilimumab","volume":"3","author":"Kwek","year":"2015","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0305","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.bjc.6601943","article-title":"The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer","volume":"91","author":"McArdle","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2015.12.022_bib0310","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/pros.22862","article-title":"Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer","volume":"74","author":"Ness","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2015.12.022_bib0315","first-page":"1621","article-title":"Dendritic and lymphocytic cell infiltration in prostate carcinoma","volume":"28","author":"Liu","year":"2013","journal-title":"Histol. Histopathol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0320","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/modpathol.2012.164","article-title":"CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancer","volume":"26","author":"Davidsson","year":"2013","journal-title":"Mod. Pathol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0325","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.ejca.2009.02.015","article-title":"Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters","volume":"45","author":"Ebelt","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2015.12.022_bib0330","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.4049\/jimmunol.177.10.7398","article-title":"CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients","volume":"177","author":"Miller","year":"2006","journal-title":"J. Immunol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0335","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00262-014-1591-2","article-title":"Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer","volume":"63","author":"Idorn","year":"2014","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1016\/j.canlet.2015.12.022_bib0340","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00262-014-1524-0","article-title":"A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates","volume":"63","author":"Jochems","year":"2014","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1016\/j.canlet.2015.12.022_bib0345","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2009.12.019","article-title":"FcRgamma activation regulates inflammation-associated squamous carcinogenesis","volume":"17","author":"Andreu","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2015.12.022_bib0350","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ccr.2014.04.026","article-title":"B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas","volume":"25","author":"Affara","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2015.12.022_bib0355","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1479-5876-12-30","article-title":"Tumor infiltrating B-cells are increased in prostate cancer tissue","volume":"12","author":"Woo","year":"2014","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.canlet.2015.12.022_bib0360","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fonc.2015.00128","article-title":"Immune Infiltration and Prostate Cancer","volume":"5","author":"Strasner","year":"2015","journal-title":"Front. Oncol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0365","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1101\/gad.220202.113","article-title":"An IKKalpha-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence","volume":"27","author":"Ammirante","year":"2013","journal-title":"Genes Dev"},{"key":"10.1016\/j.canlet.2015.12.022_bib0370","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature14395","article-title":"Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy","volume":"521","author":"Shalapour","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2015.12.022_bib0375","article-title":"The biology of circulating tumor cells","author":"Pantel","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.12.022_bib0380","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"De Craene","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2015.12.022_bib0385","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrclinonc.2014.82","article-title":"Circulating tumour cells-monitoring treatment response in prostate cancer","volume":"11","author":"Miyamoto","year":"2014","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0390","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10555-013-9488-7","article-title":"RANK-mediated signaling network and cancer metastasis","volume":"33","author":"Chu","year":"2014","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.canlet.2015.12.022_bib0395","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/ERC-13-0548","article-title":"RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization","volume":"21","author":"Chu","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.canlet.2015.12.022_bib0400","article-title":"Metastasis-initiating cells (MICs) as predictors of lethal progression of human prostate cancer","author":"Chu","year":"2014","journal-title":"Prostate Cancer Fundation Research Retreats"},{"key":"10.1016\/j.canlet.2015.12.022_bib0405","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ajpath.2010.12.003","article-title":"Circulating tumor cells as a window on metastasis biology in lung cancer","volume":"178","author":"Hou","year":"2011","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0410","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrclinonc.2013.253","article-title":"Molecular analysis of circulating tumour cells-biology and biomarkers","volume":"11","author":"Krebs","year":"2014","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0415","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1200\/JCO.2010.33.3716","article-title":"Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer","volume":"30","author":"Hou","year":"2012","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0420","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cell.2009.11.025","article-title":"Tumor self-seeding by circulating cancer cells","volume":"139","author":"Kim","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2015.12.022_bib0425","article-title":"Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics","volume":"4","author":"Ziaee","year":"2015","journal-title":"Transl. Androl. Urol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0430","series-title":"Metastasis-initiating cells (MICs) of circulating tumor cells (CTCs) as predictors of lethal progression of human prostate cancer, 6th Annual SOCCI Research Day","author":"Chu","year":"2015"},{"key":"10.1016\/j.canlet.2015.12.022_bib0435","doi-asserted-by":"crossref","first-page":"15152","DOI":"10.1073\/pnas.93.26.15152","article-title":"Androgen-repressed phenotype in human prostate cancer","volume":"93","author":"Zhau","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2015.12.022_bib0440","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/(SICI)1097-4644(1997)28\/29+<174::AID-JCB21>3.0.CO;2-G","article-title":"Development of human prostate cancer models for chemoprevention and experimental therapeutics studies","volume":"28\u201329","author":"Chung","year":"1997","journal-title":"J. Cell. Biochem. Suppl"},{"key":"10.1016\/j.canlet.2015.12.022_bib0445","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10585-008-9183-1","article-title":"Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model","volume":"25","author":"Zhau","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2015.12.022_bib0450","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","article-title":"5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy","volume":"21","author":"Christman","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.12.022_bib0455","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature13229","article-title":"Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer","volume":"510","author":"Asangani","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2015.12.022_bib0460","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.18632\/oncotarget.1534","article-title":"BET bromodomain protein inhibition is a therapeutic option for medulloblastoma","volume":"4","author":"Henssen","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2015.12.022_bib0465","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/2159-8290.CD-12-0418","article-title":"Targeting MYCN in neuroblastoma by BET bromodomain inhibition","volume":"3","author":"Puissant","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.canlet.2015.12.022_bib0470","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2015.12.022_bib0475","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrc2223","article-title":"The emerging roles of forkhead box (Fox) proteins in cancer","volume":"7","author":"Myatt","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2015.12.022_bib0480","doi-asserted-by":"crossref","first-page":"e34329","DOI":"10.1371\/journal.pone.0034329","article-title":"FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma","volume":"7","author":"Teh","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2015.12.022_bib0485","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1002\/cncr.28354","article-title":"Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas","volume":"119","author":"Hwang","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2015.12.022_bib0490","doi-asserted-by":"crossref","first-page":"9515","DOI":"10.1158\/0008-5472.CAN-10-2173","article-title":"Induction of human epithelial stem\/progenitor expansion by FOXM1","volume":"70","author":"Gemenetzidis","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0495","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1158\/0008-5472.CAN-06-1576","article-title":"Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1","volume":"66","author":"Radhakrishnan","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0500","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.biocel.2012.08.007","article-title":"Exosomes: new players in cell-cell communication","volume":"44","author":"Bang","year":"2012","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0505","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ki.2010.278","article-title":"Exosomes\/microvesicles as a mechanism of cell-to-cell communication","volume":"78","author":"Camussi","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.canlet.2015.12.022_bib0510","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tcb.2008.11.003","article-title":"Shedding microvesicles: artefacts no more","volume":"19","author":"Cocucci","year":"2009","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0515","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.4161\/cc.26539","article-title":"Large oncosomes mediate intercellular transfer of functional microRNA","volume":"12","author":"Morello","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2015.12.022_bib0520","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1158\/0008-5472.CAN-08-3860","article-title":"Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease","volume":"69","author":"Di Vizio","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0525","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/emmm.201200242","article-title":"DIAPH3 governs the cellular transition to the amoeboid tumour phenotype","volume":"4","author":"Hager","year":"2012","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.canlet.2015.12.022_bib0530","first-page":"108","article-title":"Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies","volume":"2014","author":"Record","year":"1841","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2015.12.022_bib0535","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.leu.2404296","article-title":"Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication","volume":"20","author":"Ratajczak","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2015.12.022_bib0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5772\/58597","article-title":"The development of stem cell-derived exosomes as a cell-free regenerative medicine","volume":"3","author":"Vishnubhatla","year":"2014","journal-title":"J. Circ. Biomark"},{"key":"10.1016\/j.canlet.2015.12.022_bib0545","doi-asserted-by":"crossref","first-page":"7309","DOI":"10.4049\/jimmunol.166.12.7309","article-title":"Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles","volume":"166","author":"Thery","year":"2001","journal-title":"J. Immunol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0550","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1182\/blood.V98.10.3143","article-title":"Platelet-derived microparticles bind to hematopoietic stem\/progenitor cells and enhance their engraftment","volume":"98","author":"Janowska-Wieczorek","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2015.12.022_bib0555","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00262-005-0075-9","article-title":"Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes","volume":"55","author":"Baj-Krzyworzeka","year":"2006","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1016\/j.canlet.2015.12.022_bib0560","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.leu.2404132","article-title":"Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery","volume":"20","author":"Ratajczak","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2015.12.022_bib0565","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0570","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1021\/pr200682z","article-title":"Proteomic analysis of microvesicles derived from human mesenchymal stem cells","volume":"11","author":"Kim","year":"2012","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0575","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ccell.2014.09.005","article-title":"Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis","volume":"26","author":"Melo","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2015.12.022_bib0580","first-page":"98","article-title":"Exosome\/microvesicle-mediated epigenetic reprogramming of cells","volume":"1","author":"Camussi","year":"2011","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib0585","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/cgt.2014.14","article-title":"Good things come in small packages: exosomes, immunity and cancer","volume":"21","author":"Wang","year":"2014","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.canlet.2015.12.022_bib0590","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses","volume":"9","author":"Thery","year":"2009","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.canlet.2015.12.022_bib0595","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1182\/blood-2007-06-097410","article-title":"Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles","volume":"111","author":"Sprague","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2015.12.022_bib0600","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3233\/CBM-2011-0211","article-title":"Tumor-derived exosomes as mediators of disease and potential diagnostic biomarkers","volume":"8","author":"Roberson","year":"2010","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.canlet.2015.12.022_bib0605","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1158\/1078-0432.CCR-10-1489","article-title":"Exosomes and cancer: a newly described pathway of immune suppression","volume":"17","author":"Zhang","year":"2011","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2015.12.022_bib9000","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immun"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515007739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515007739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T14:41:28Z","timestamp":1556376088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383515007739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0304383515007739"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2015.12.022","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of prostate cancer progression by the tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2015.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}